A Guide for Pain Management in Developing Nations: The Diagnosis and Assessment of Pain in Cancer Patients
- Authors
-
-
Joseph V. Pergolizzi
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA 2Department of Anesthesiology, Georgetown University School of Medicine, Washington, D.C., USA 3Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA -
Gianpietro Zampogna
NEMA Research, Naples, Florida, USA -
Robert Taylor
NEMA Research, Naples, Florida, USA -
Marixa Guerrero
Medical Director of Instituto de Ortopedia Roosevelt, Bogota, Colombia -
Juan Quillermo Santacruz
Palliativist of Fundacion Santa fe, Bogota, Colombia -
Robert B. Raffa
Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA
-
- Keywords:
- Cancer pain, malignant pain, opioid analgesia, opioids, undertreatment of cancer pain, assessment of cancer pain.
- Abstract
-
The fundamental approach to cancer patients with pain is to identify the pain sites, and describe, quantify, and categorize the pain by type at each site. There are many validated tools to serve the clinician in these efforts, particularly for pain assessment. Multimechanistic pain syndromes are common in cancer patients. Cancer patients may experience nociceptive pain. They may also experience neuropathic pain due to chemotherapy-induced or cancer-related nerve damage. Analgesic choices must be guided by the pain mechanisms, nature, and severity of the pain, comorbid conditions, and patient characteristics. Long-acting opioid analgesics or fixed-clock dosing can eliminate end-of-dose analgesic gaps. The potential for opioid abuse is an important public health challenge but one that should not undermine the appropriate treatment of moderate to severe cancer pain. Abuse-deterrent opioid formulations can be useful. Care is needed for special populations of cancer patients dealing with pain, such as geriatric, pediatric, or obese patients. While morphine has long been the gold standard of oral opioid products, recent clinical trials suggest that oral hydrocodone and oral oxycodone may offer advantages over oral morphine. Patient adherence is crucial for adequate analgesia and patient education can promote adherence and manage expectations.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 14-01-2016
- Issue
- Vol. 5 No. 1 (2016)
- Section
- Articles
How to Cite
Similar Articles
- Huan Liu, Haijuan Wang, Haili Qian, Cancer Metastasis and Cancer Stem Cells , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)
- Sisir Nandi, Manish C. Bagchi, EGFr, FGFr and PDGFr: Emerging Targets for Anticancer Drug Design , Journal of Cancer Research Updates: Vol. 5 No. 3 (2016)
- Michael T. Hardin, Amy S. Harrison, Virginia L. Lockamy, Jun Li, Cheng Peng, Peter Potrebko, Yan Yu, Laura Doyle, Junsheng Cao, Evaluation of the Type and Frequency of Errors Discovered During Routine Secondary Patient Chart Review , Journal of Cancer Research Updates: Vol. 6 No. 1 (2017)
- Nikhil Vasdev, Patricia McClurey, Debra Gray, Aftab Bhatti, David Chadwick, An Audit to Evaluate the Clinical Safety and PSA Response of Firmagon® (Degarelix) in Patients with Advanced Metastatic Prostate Cancer - , Journal of Cancer Research Updates: Vol. 2 No. 1 (2013)
- Joseph V. Pergolizzi, Jr., Jo Ann LeQuang, Sigma Antagonists for Treatment of Neuropathic Pain Syndromes in Cancer Patients: A Narrative Review , Journal of Cancer Research Updates: Vol. 11 (2022)
- Kamal Asadipour, Narendra Banerjee, Jazmine Cuffee, Karrington Perry, Shennel Brown, Anasua Banerjee, Erik Armstrong, Stephen Beebe, Hirendra Banerjee, Studying the Role of Novel Carbon Nano Tubes as a Therapeutic Agent to Treat Triple Negative Breast Cancer (TNBC) - an In Vitro and In Vivo Study , Journal of Cancer Research Updates: Vol. 13 (2024)
- Dhafer A. Alghezi, Rasha Aljawher, Hameed Naeem Mosa, Increased KI67 Immunostaining is Associated with Breast Cancer Aggressiveness , Journal of Cancer Research Updates: Vol. 14 (2025)
- Susmitha Kasina, Hemant K.S. Yadav, H.G. Shivakumar , Breast Cancer – Diagnosis and Treatment Prolonging Life: A Review , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)
- Shaimaa A. Soliman, Laila A. Rashed, Mahmoud M. Said, Amina M. Medhat, Assessment of Gene Expression Level of ATP Binding Cassette G Member 2 (ABCG2) Transporter in Newly Diagnosed Breast Cancer Patients Receiving Adjuvant Chemotherapy , Journal of Cancer Research Updates: Vol. 8 No. 1 (2019)
- Praneet Singh Bedi, Meenu Walia, Vipulkumar Thummar, Priya Mehta, A Case Report on Prolonged Response with Trastuzumab Emtansine (T-DM1) in Recurrent Advance Breast Cancer Setting , Journal of Cancer Research Updates: Vol. 12 (2023)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Joseph V. Pergolizzi Jr., Robert B. Raffa, Emilio Esteban Gonzalez, Jo Ann LeQuang, A Guide for Cancer Pain Management in Latin America , Journal of Cancer Research Updates: Vol. 6 No. 4 (2017)
- Joseph V. Pergolizzi Jr, Robert Taylor Jr, Gianpietro Zampogna, Fuat H. Demirelli, Serdar Erdine, Robert B. Raffa, Oxycodone Immediate Release for Cancer Pain Management in Turkey: Maximizing Value in Opioid Analgesics , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)